Alzheimer's disease

FILE - In this Aug. 14, 2018 file photo, a doctor looks at PET brain scans in Phoenix. A big study to help Medicare officials decide whether to start covering brain scans to check for Alzheimer’s disease missed its goals for curbing emergency room visits and hospitalizations. The results announced Thursday, July 30, 2020 call into question whether the costly tests are worth it for a disease that currently has no cure. (AP Photo/Matt York, File)
1010 WINS Newsroom
July 30, 2020 - 9:35 am
A big study to help Medicare officials decide whether to start covering brain scans to check for Alzheimer’s disease missed its goals for curbing health care costs, calling into question whether the pricey tests are worth it. The results announced Thursday are from a $100 million study of more than...
Read More
In this image from video provided by Washington University, researcher Nicolas Barthelemy works on a p-tau217 test for Alzheimer's disease at a laboratory in St. Louis, Mo., on Monday, July 27, 2020. Several companies and universities have developed versions of these tests, which look for a form of tau protein, one of the substances that can build up and damage the brains of people with Alzheimer’s. (Huy Mach/University of Washington via AP)
1010 WINS Newsroom
July 28, 2020 - 1:11 pm
An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia. Developing such a test has been a long-sought goal, and...
Read More
Alzheimers
Getty Images
1010 WINS Newsroom
February 21, 2020 - 9:29 am
Governor Andrew Cuomo announced on Friday a 30-day amendment to the FY 2021 Executive Budget which will include legislation to establish the SUNY Curing Alzheimer's Health Consortium within the State University of New York.
Read More
FILE - In this Aug. 14, 2018 file photo, a doctor looks at a PET brain scan at the Banner Alzheimers Institute in Phoenix. Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because of rare gene flaws. The results announced Monday, Feb. 10, 2020, are another disappointment for the approach that scientists have focused on for many years -- trying to remove a harmful protein that builds up in the brains of people with the disease. (AP Photo/Matt York, File)
1010 WINS Newsroom
February 10, 2020 - 8:04 am
Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because they inherited rare gene flaws. The results announced Monday are another disappointment for the approach that scientists...
Read More
In this Nov. 22, 2019, photo, Charles Flagg, who is stricken with Alzheimer's disease, receives the contents of an intravenous bag while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
1010 WINS Newsroom
December 05, 2019 - 3:20 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
1010 WINS Newsroom
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
1010 WINS Newsroom
November 12, 2019 - 5:40 pm
SAN FRANCISCO (AP) — Billionaire philanthropists Joan and Sandy Weill announced Tuesday they are donating $106 million to launch a research initiative at three West Coast universities aimed at finding treatments for brain disorders like epilepsy and Alzheimer's disease. The donation to the...
Read More
FILE - In this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement Tuesday, Oct. 22, 2019, is a surprise because the company earlier this year stopped two studies of the drug, called aducanumab, after partial results suggested it was not working. (AP Photo/Matt York, File)
1010 WINS Newsroom
October 22, 2019 - 6:44 pm
Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement was a surprise because the drug company earlier this year stopped two...
Read More
This microscope image shows the 46 human chromosomes, blue, with telomeres appearing as white pinpoints. Research released on Tuesday, July 16, 2019 offers some of the first biological clues to why women may be more likely than men to develop Alzheimer's disease, and how this most common form of dementia varies by gender. (Hesed Padilla-Nash, Thomas Ried/National Cancer Institute/National Institutes of Health via AP)
July 16, 2019 - 3:10 pm
LOS ANGELES (AP) — New research gives some biological clues to why women may be more likely than men to develop Alzheimer's disease and how this most common form of dementia varies by sex. At the Alzheimer's Association International Conference in Los Angeles on Tuesday, scientists offered evidence...
Read More
In this July 9, 2019 photo, Dr. Jori Fleisher, neurologist, examines Thomas Doyle, 66, at the Rush University Medical Center in Chicago. Doyle, 66, hopes blood tests may someday replace the invasive diagnostic testing he endured to be diagnosed 4.5 years ago with Lewy body dementia. (AP Photo/Teresa Crawford)
July 15, 2019 - 4:02 pm
LOS ANGELES (AP) — Scientists are closing in on a long-sought goal — a blood test to screen people for possible signs of Alzheimer's disease and other forms of dementia. On Monday at the Alzheimer's Association International Conference, half a dozen research groups gave new results on various...
Read More

Pages